• CareSpan (CSPN) offers integrated digital tools to empower patients and health care practitioners
  • Its flagship Clinic-in-the-Cloud workflow platform supports both in-person and telehealth care
  • Melissa Magstadt, CEO of American APN, CareSpan’s nurse practitioner network, spoke with Daniella Atkinson about how the company is working with nurse practitioners to address U.S. health care shortages
  • CareSpan is a health care technology and services company improving patient outcomes through integrated digital care
  • CareSpan Health (CSPN) opened trading at $0.20 per share

CareSpan (CSPN) offers integrated digital tools to empower patients and health care practitioners.

Its proprietary Clinic-in-the-Cloud workflow platform integrates remote patient monitoring, diagnostic tools, electronic health records, as well as e-prescribing and lab ordering whether for in-person or telehealth care.

The company is using its platform to build provider networks across the U.S. that deliver primary, chronic, urgent and behavioral health care to underserved populations.

Melissa Magstadt, CEO of American APN, CareSpan’s nurse practitioner network, spoke with Daniella Atkinson about how the company is addressing U.S. shortages in primary, chronic and urgent care.

Topics discussed include nurse practitioners’ key role in meeting the demand for quality health care and how CareSpan technology enhances their service now and into the future.

CareSpan is a health care technology and services company improving patient outcomes through integrated digital care.

CareSpan Health (CSPN) opened trading at $0.20 per share.


More From The Market Online

@ the Bell: Dow Jones reaches 40,000 milestone

The Dow Jones Industrial Average reached a key milestone – the 40,000 mark, which it had never reached. Canada’s main stock index also rose.
The Market Online Video

High-quality lithium projects in Argentina with drilling underway

Argentina Lithium & Energy (TSXV:LIT) is focused on acquiring high-quality lithium projects and advancing them towards production.

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.